DAFNA Capital Management as of March 31, 2016
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 93 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| AtriCure (ATRC) | 7.1 | $8.2M | 488k | 16.83 | |
| Abbvie (ABBV) | 5.7 | $6.7M | 117k | 57.12 | |
| NxStage Medical | 5.1 | $5.9M | 397k | 14.99 | |
| Vitae Pharmaceuticals | 4.5 | $5.2M | 787k | 6.63 | |
| Rigel Pharmaceuticals | 3.4 | $3.9M | 1.9M | 2.08 | |
| Dermira | 3.1 | $3.6M | 172k | 20.68 | |
| Insulet Corporation (PODD) | 3.0 | $3.5M | 106k | 33.16 | |
| Alder Biopharmaceuticals | 3.0 | $3.4M | 140k | 24.49 | |
| Marinus Pharmaceuticals | 2.6 | $3.0M | 567k | 5.38 | |
| Neurocrine Biosciences (NBIX) | 2.6 | $3.0M | 76k | 39.55 | |
| Novavax | 2.5 | $2.9M | 554k | 5.16 | |
| Biotelemetry | 2.4 | $2.8M | 236k | 11.68 | |
| Galapagos Nv- (GLPG) | 2.4 | $2.7M | 66k | 41.82 | |
| Regulus Therapeutics | 2.3 | $2.7M | 392k | 6.93 | |
| Applied Genetic Technol Corp C | 2.0 | $2.3M | 167k | 13.98 | |
| Insulet Corp note 2.000% 6/1 | 2.0 | $2.3M | 2.4M | 0.97 | |
| Aerie Pharmaceuticals | 1.9 | $2.2M | 180k | 12.16 | |
| Masimo Corporation (MASI) | 1.7 | $1.9M | 46k | 41.84 | |
| Uniqure Nv (QURE) | 1.6 | $1.9M | 159k | 11.88 | |
| Achillion Pharmaceuticals | 1.6 | $1.8M | 237k | 7.72 | |
| Cara Therapeutics (CARA) | 1.4 | $1.7M | 267k | 6.22 | |
| Protalix Biotherapeutics Inc note 4.500% 9/1 | 1.4 | $1.7M | 2.5M | 0.66 | |
| iShares NASDAQ Biotechnology Index (IBB) | 1.4 | $1.6M | 6.0k | 260.83 | |
| Stereotaxis (STXS) | 1.3 | $1.5M | 1.4M | 1.10 | |
| BioSpecifics Technologies | 1.2 | $1.4M | 40k | 34.81 | |
| Xenon Pharmaceuticals (XENE) | 1.2 | $1.4M | 193k | 6.99 | |
| Radius Health | 1.1 | $1.3M | 43k | 31.43 | |
| Celyad Sa | 1.1 | $1.3M | 30k | 44.17 | |
| Ldr Hldg | 1.1 | $1.3M | 50k | 25.49 | |
| Spectranetics Corporation | 1.0 | $1.2M | 80k | 14.52 | |
| Novadaq Technologies | 1.0 | $1.1M | 102k | 11.09 | |
| Derma Sciences | 0.9 | $1.1M | 354k | 3.10 | |
| Ardelyx (ARDX) | 0.9 | $1.1M | 140k | 7.77 | |
| Loxo Oncology | 0.9 | $1.1M | 39k | 27.33 | |
| Johnson & Johnson (JNJ) | 0.9 | $1.0M | 9.4k | 108.19 | |
| Macrogenics (MGNX) | 0.9 | $1.0M | 54k | 18.75 | |
| Ascendis Pharma A S (ASND) | 0.8 | $988k | 53k | 18.56 | |
| Lipocine | 0.8 | $972k | 96k | 10.15 | |
| MediciNova (MNOV) | 0.8 | $918k | 125k | 7.34 | |
| Discovery Laboratories | 0.8 | $891k | 533k | 1.67 | |
| Synergy Pharmaceuticals | 0.7 | $813k | 295k | 2.76 | |
| Foamix Pharmaceuticals | 0.7 | $774k | 119k | 6.52 | |
| Aldeyra Therapeutics (ALDX) | 0.6 | $738k | 176k | 4.19 | |
| Avalanche Biotechnologies In | 0.6 | $727k | 141k | 5.17 | |
| Zogenix | 0.6 | $734k | 79k | 9.24 | |
| Adaptimmune Therapeutics (ADAP) | 0.6 | $716k | 88k | 8.13 | |
| Adamas Pharmaceuticals | 0.6 | $687k | 48k | 14.46 | |
| Caredx (CDNA) | 0.6 | $675k | 136k | 4.96 | |
| Tobira Therapeutics Inc Common Stock Usd 0.0001 | 0.6 | $666k | 81k | 8.18 | |
| Essa Pharma | 0.6 | $662k | 203k | 3.27 | |
| Dicerna Pharmaceuticals | 0.6 | $646k | 121k | 5.36 | |
| Cynapsus Therapeutics | 0.6 | $649k | 53k | 12.25 | |
| Exactech | 0.6 | $641k | 32k | 20.26 | |
| Scynexis | 0.6 | $632k | 157k | 4.03 | |
| Edge Therapeutics | 0.6 | $633k | 69k | 9.15 | |
| Syneron Medical Ltd ord | 0.5 | $628k | 86k | 7.31 | |
| Akebia Therapeutics (AKBA) | 0.5 | $592k | 66k | 9.01 | |
| Beigene (BGNE) | 0.5 | $586k | 20k | 29.30 | |
| Ironwood Pharma note 2.25% 15-jun-2022 144a sr unsecured conv | 0.5 | $546k | 600k | 0.91 | |
| Targacept Inc Conv Dtd convertible | 0.5 | $531k | 531k | 1.00 | |
| Bluebird Bio (BLUE) | 0.4 | $510k | 12k | 42.50 | |
| Endologix, Inc. 3.25% 11/01/2020 | 0.4 | $495k | 500k | 0.99 | |
| Cardica | 0.4 | $499k | 140k | 3.56 | |
| Intec Pharma | 0.4 | $492k | 119k | 4.12 | |
| Arbutus Biopharma (ABUS) | 0.4 | $476k | 115k | 4.13 | |
| Abeona Therapeutics | 0.4 | $466k | 182k | 2.56 | |
| BioCryst Pharmaceuticals (BCRX) | 0.4 | $424k | 150k | 2.83 | |
| Cynapsus Therapeutics | 0.4 | $416k | 34k | 12.24 | |
| Neos Therapeutics | 0.4 | $419k | 39k | 10.78 | |
| Nemus Bioscience | 0.3 | $401k | 580k | 0.69 | |
| Cytokinetics (CYTK) | 0.3 | $392k | 56k | 7.05 | |
| Cogentix Medical | 0.3 | $388k | 353k | 1.10 | |
| Vtv Therapeutics Inc- Cl A | 0.3 | $377k | 73k | 5.16 | |
| Tandem Diabetes Care | 0.3 | $318k | 37k | 8.70 | |
| Check Cap | 0.2 | $245k | 89k | 2.75 | |
| Sunesis Pharmaceuticals | 0.2 | $229k | 423k | 0.54 | |
| Venaxis | 0.2 | $201k | 74k | 2.70 | |
| INSTRS INC Stemcells | 0.2 | $182k | 700k | 0.26 | |
| Affimed Therapeutics B V | 0.1 | $175k | 47k | 3.75 | |
| Tenax Therapeutics | 0.1 | $163k | 80k | 2.05 | |
| Biopharmx | 0.1 | $160k | 147k | 1.09 | |
| Catalyst Biosciences | 0.1 | $119k | 71k | 1.68 | |
| Pieris Pharmaceuticals | 0.1 | $95k | 50k | 1.89 | |
| Genvec | 0.1 | $77k | 96k | 0.80 | |
| Cel-sci | 0.1 | $68k | 128k | 0.53 | |
| Galmed Pharmaceuticals | 0.1 | $66k | 14k | 4.89 | |
| Pronai Therapeutics | 0.1 | $67k | 10k | 6.70 | |
| Akari Therapeutics | 0.1 | $66k | 4.7k | 13.92 | |
| Nivalis Therapeutics | 0.1 | $63k | 15k | 4.20 | |
| Check Cap Ltd w exp 02/28/202 | 0.0 | $42k | 54k | 0.78 | |
| Antares Pharma | 0.0 | $39k | 45k | 0.87 | |
| Enteromedics | 0.0 | $32k | 33k | 0.96 | |
| Neuroderm Ltd F | 0.0 | $17k | 1.2k | 14.14 |
